PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes
Cyclic nucleotide phosphodiesterases 4 (PDE4) are a family of enzymes which specifically promote the hydrolysis and degradation of cAMP. The inhibition of PDE4 enzymes has been widely investigated as a possible alternative strategy for the treatment of a variety of respiratory diseases, including ch...
Main Authors: | Jian Jin, Francesca Mazzacuva, Letizia Crocetti, Maria Paola Giovannoni, Agostino Cilibrizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/14/11518 |
Similar Items
-
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
by: Letizia Crocetti, et al.
Published: (2022-08-01) -
Clinical Implication of Phosphodiesterase-4-Inhibition
by: Martin Alexander Schick, et al.
Published: (2022-01-01) -
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
by: Andrew Blauvelt, et al.
Published: (2023-11-01) -
The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
by: Claire Lugnier
Published: (2022-09-01) -
Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
by: Marianna Szczypka
Published: (2020-08-01)